Effects of Nicotine on Urinary Bladder Carcinogenesis
Pathology International · 2026-07 · 76 (7)
DOI: 10.1111/pin.70151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology International, online erschienen am 15.07.2026. Verfasst von Shugo Suzuki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Nicotine, Urinary Bladder Neoplasms, Carcinogenesis. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ono Pharmaceutical Co., Ltd, Smoking Research Foundation.
Abstract (Originalsprache)
Epidemiological evidence has consistently demonstrated an association between tobacco smoking and an increased risk of urinary bladder cancer. However, the specific role of nicotine, independent from established genotoxic carcinogens such as aromatic amines, has not been clarified. This review summarises experimental evidence regarding the carcinogenic effects of nicotine and the underlying molecular mechanisms in urinary bladder carcinogenesis. In a two‐stage rat carcinogenesis model, nicotine administration significantly increased the incidence and multiplicity of invasive urothelial carcinoma. In contrast, nicotine treatment alone increased hyperplasia but did not induce the formation of tumors, suggesting that nicotine functions as an enhancing agent for tumorigenesis, rather than as a DNA reactive agent. Mechanistically, nicotine has been shown to induce cell proliferation through two distinct pathways. One involves the activation of nicotinic acetylcholine receptors (nAChRs), particularly the α7 subunit, leading to activation of STAT3 and ERK1/2 signalling pathway. The other involves urothelial cytotoxicity followed by regenerative increased cell proliferation. In addition, cotinine, the major urinary metabolite of nicotine, was found to induce proliferation via nAChRs, without inducing cytotoxicity. These findings indicate that nicotine exposure may contribute to bladder cancer risk through mechanisms involving increased cell proliferation, either due to direct mitogenesis or secondary to cytotoxicity and regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Pathology, Microbiology and Immunology, and Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Sylvia Havlik Centennial Professor of Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
ORCID-Profile: Shugo Suzuki
Förderung
- Ono Pharmaceutical Co., Ltd
- Smoking Research Foundation
Zitieren
APA
Suzuki, S., & Cohen, S. M. (2026). Effects of Nicotine on Urinary Bladder Carcinogenesis. Pathology International, 76(7). https://doi.org/10.1111/pin.70151
Vancouver
Suzuki S, Cohen SM. Effects of Nicotine on Urinary Bladder Carcinogenesis. Pathology International. 2026;76(7). doi:10.1111/pin.70151
BibTeX
@article{Suzuki2026,
author = {Suzuki, Shugo and Cohen, Samuel M},
title = {Effects of Nicotine on Urinary Bladder Carcinogenesis},
journal = {Pathology International},
year = {2026},
volume = {76},
number = {7},
doi = {10.1111/pin.70151}
}
EUVIMED